Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
4C Biomed Logo
4C Biomed CB Rank
476262
Heat Score
55
4C Biomed is a biotechnology company that works in drug discovery in the field of cancer immunotherapy.
Founded
obfuscation
Private London, England, United Kingdom1-10 www.4cbiomed.com
Biotechnology
Oncology
Therapeutics
Overview

4C Biomed
Heat Score
55

Growth Score
pts
in past quarter
Heat Score 55
-31 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About 4C Biomed

CB Rank
476262
4C Biomed is a biotechnology company that works in drug discovery in the field of cancer immunotherapy.
Founded
obfuscation
Private London, England, United Kingdom1-10 www.4cbiomed.com
Biotechnology
Oncology
Therapeutics

Key People

Details

Legal Name 4CBiomed Ltd.
Operating Status Active
Company Type For Profit
Founders  Eyal Greenberg, Gal Markel, Jacob Schachter, Tony Angel
Phone Number 972 977-99-188
Contact Email office@4cbiomed.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Anti-4CB1
A fully human monoclonal antibody designed to block the HVEM-BTLA interaction, enhancing lymphocyte cytotoxicity against tumor cells, currently in IND-enabling studies with plans for clinical Phase I trials in 2025.
Immunological-based Screening Platform
A platform using patient-derived materials to identify targets for drug discovery and development, focusing on immune checkpoint inhibitors for cancer immunotherapy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4 Contacts 5

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

37
-46.38%
 in past month

IT Spend

$43KThis year, 4C Biomed is projected to spend $43K on IT, according to Aberdeen.

Active Website Tech Count

14C Biomed is actively using the technology Euro for its website, according to BuiltWith.

Total IP

2The intellectual property of 4C Biomed includes 2 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is 4C Biomed's headquarters? 4C Biomed is located in London, England, United Kingdom.Who are 4C Biomed's competitors? Alternatives and possible competitors to 4C Biomed may include Roche, Merck, and  Bristol-Myers Squibb.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c8221c2 1)
|